Related Experiment Videos
Nerve growth factor and diabetic neuropathy
1The Leonard Strelitz Diabetes Institutes, Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, Virginia 23510, USA. pittengl@evms.edu
Experimental Diabesity Research
|December 12, 2003
Summary
Diabetic neuropathy, a common complication, may stem from deficiencies in neurotrophic factors essential for nerve health and regeneration. Future therapies targeting these factors show promise for treating nerve damage in diabetes.
Area of Science:
- Neuroscience
- Endocrinology
- Diabetology
Background:
- Diabetic neuropathy is a severe complication affecting 50-90% of individuals with type 1 and type 2 diabetes.
- Neuronal damage in diabetes involves both large and small nerve fibers.
- Experimental evidence links neuronal abnormalities to deficiencies in neurotrophic factors.
Purpose of the Study:
- To explore the role of neurotrophic factors in the pathogenesis of diabetic neuropathy.
- To investigate the potential of neurotrophic factor-based therapies for diabetic neuropathy.
Main Methods:
- Review of experimental models and clinical studies on neurotrophic factors in diabetes.
- Analysis of the impact of neurotrophic factor depletion on neuronal function and survival.
- Examination of the role of nerve growth factor (NGF), neurotrophin-3 (NT3), and insulin-like growth factors (IGFs).
Main Results:
- Reduced availability of neurotrophic factors, including NGF, substance P (SP), and calcitonin gene-related peptide (CGRP), is observed in diabetes.
- These deficiencies may arise from metabolic issues or be independent of glycemic control.
- Neurotrophic factors are crucial for neuronal maintenance, apoptosis resistance, and regeneration.
Conclusions:
- Deficiencies in neurotrophic factors contribute to nerve fiber dysfunction and diabetic neuropathy symptoms.
- While early human trials were unsuccessful, ongoing research suggests potential for future neurotrophic factor therapies.
- Targeted neurotrophic factor treatments hold promise for managing diabetic neuropathy by addressing specific nerve fiber populations.